Booster doses are essential, especially with haematological cancer or any cancer undergoing treatment.

Takeaway

• A population-based cohort of nearly 1.5 million people finds that cancer patients who have received 2 COVID-19 vaccinations are at greater risk for breakthrough SARS-CoV-2 infection and severe outcomes than matched noncancer controls.
• Patients with...